Epinex Diagnostics
Epinex Diagnostics: Innovating medical products for efficient diabetes identification.
Founded
2002Epinex Diagnostics: Innovating medical products for efficient diabetes identification.
Epinex Diagnostics, a medical diagnostics company, was founded with the mission to innovate and improve the identification and management of diabetes. The company's core vision is to develop efficient and accessible diagnostic tools for underserved markets. Epinex offers products such as the G1A Test, which focuses on better diabetes control by measuring glycated albumin, and other tests like the ACR Test and Simply-Sure PT INR Test. Their market focus is primarily on providing advanced diagnostic solutions to enhance diabetes care.
Notable affiliated people and investors include experts in medical diagnostics and technology sectors, although specific names are not provided. Key achievements include the development of the G1A Test, which represents a significant advancement in diabetes monitoring, though it is still under development and not yet FDA-approved. Epinex Diagnostics' overall impact lies in its commitment to addressing the challenges of diabetes through innovative testing solutions, aiming to improve patient outcomes and healthcare efficiency.
Companies similar to Epinex Diagnostics include Diabetomics, Empowered Diagnostics, Mellitus and Eclipse Diagnostics.
Epinex Diagnostics was founded in 2002.
Epinex Diagnostics' headquarters is located in Tustin, CA, US.
Epinex Diagnostics' most recent funding round was for $100k (USD) in February 2016.
As of Feb 14, 2016, Epinex Diagnostics has disclosed funding of $4.6M (USD). Undisclosed round amounts are excluded.
Epinex Diagnostics has 22 employees as of Feb 5, 2024.
Eclipse Diagnostics
